Norwegian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
antifungal/nausea
Koblingen er lagret på utklippstavlen
Side 1 fra 29 resultater
Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
TECHNICAL FIELD
The present invention relates to the field of therapeutic uses for erythropoietin, and more particularly, to treating subjects with a recombinant erythropoietin prepared from an Apa I human genomic DNA fragment, including recombinant erythropoietin expressed in transformed baby
Pharmaceutical preparations for the treatment of itch, nausea, hyperalgesia and the complications of opioid agonists
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is relevant to the field of suppressing sensory afferent neuron mediated symptoms and the manufacture of agents and compositions which suppress the same.
2. Discussion of the Related Art.
Sensory afferent nerves mediate a
Therapeutic patch
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND
Nausea associated symptoms can severely disrupt daily normal activity. In modern societies, a hectic lifestyle is common. Dealing with a disruption in that lifestyle may lower quality of life and may induce many other ailments such as for example, anxiety and stress. In addition, nausea
Novel method of administering anti-nausea and anti-emetic pharmaceutical agents and novel dosage forms containing same
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF INVENTION
1. Field of the Invention
The present invention relates to a novel method of administering anti nausea and anti emetic agents and to novel dosage forms containing such agents adapted for nasal administration.
The invention provides a novel method of administering therapeutic
Method for treating nausea and vomiting
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
This invention relates to a new medical use for a group of heterocyclic compounds and pharmaceutical compositions containing them. In particular it relates to certain tetrahydrocarbazolone derivatives which may be used to promote gastric emptying and as anti-emetic agents.
A particularly important
Sulphonamide derivatives, their preparation and their therapeutic application
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
FIELD OF THE INVENTION
The present invention relates to sulfonamide derivatives, to the process for preparing them and to their therapeutic use.
BACKGROUND OF THE INVENTION
Orexins A and B (or hypocretins 1 and 2) are hypothalamus neuropeptides of 33 and 28 amino acids, respectively, recently
2-{4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluorop yrimidine, its preparation and its therapeutic use
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
The present invention relates to the novel compound 2-{4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoro pyrimidine, its preparation and its therapeutic use, its physiologically acceptable salts, the processes for their preparation and their application as medicaments in human
Aromatic amides of heterocyclic compounds and therapeutic compositions containing same
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
SUMMARY OF THE INVENTION
According to our invention, in its broadest aspect, we provide a compound corresponding to the general formula (I): ##STR1## in which: R is a lower (C.sub.1 -C.sub.6) alkoxy or alkenoxy;
R.sub.1 and R.sub.2, which may be the same or different, are selected from hydrogen,
Therapeutic compounds
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
Propofol (2,6-diisopropylphenol) is an intravenous sedative/hypnotic agent used extensively for induction and maintenance of general anesthesia, sedation of critically ill patients and procedural sedation (e.g., endoscopy). See Langly, M. S. and Heel, R. C. Drugs, 1988, 35, 334-372. Propofol is only
Therapeutic use and formulation
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
FIELD OF THE INVENTION
This invention relates to new therapeutic uses of tramadol and its structural and/or functional analogues, and to new formulations thereof.
BACKGROUND OF THE INVENTION
Tramadol has the chemical name (+/-)-trans (RR,SS)-2-[(di-methylamino)methyl]-1-(3-methoxyphenyl)
Method of treatment of nausea, vomiting, and other disorders using estrogens
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
CROSS-REFERENCE TO RELATED APPLICATIONS
Not applicable.
STATEMENT REGARDING FEDERALLY SPONSERED RESEARCH OR DEVELOPMENT
Not applicable.
REFERENCE TO A MICROFICHE APPENDIX
Not applicable.
BACKGROUND OF THE INVENTION
1. Field of the Invention
A new use for estrone, derivatives of estrone, equilin and
Treatment method
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
FIELD OF THE INVENTION
The invention relates to methods of treating mammals, for example humans, to reduce the occurrence of undesired administration reactions, to treat an LFA-1 mediated disease, to condition a mammal to tolerate high doses of a therapeutic compound and to down modulate a cell
Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
FIELD OF THE INVENTION
The invention relates to methods of treating mammals, for example humans, to reduce the occurrence of undesired administration reactions, to treat an LFA-1 mediated disease, to condition a mammal to tolerate high doses of a therapeutic compound and to down modulate a cell
Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
FIELD OF THE INVENTION
The invention relates to methods of treating mammals, for example humans, to reduce the occurrence of undesired administration reactions, to treat an LFA-1 mediated disease, to condition a mammal to tolerate high doses of a therapeutic compound and to down modulate a cell
.DELTA.9 Tetrahydrocannabinol (.DELTA.9 THC) solution metered dose inhaler
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
DESCRIPTION
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention is generally related to the therapeutic use of .DELTA..sup.9 Tetrahydrocannabinol (.DELTA..sup.9 THC). In particular, the invention provides a metered dose inhaler (MDI) for the aerosol administration of .DELTA..sup.9
Den mest komplette databasen med medisinske urter støttet av vitenskap
- Fungerer på 55 språk
- Urtekurer støttet av vitenskap
- Urtegjenkjenning etter bilde
- Interaktivt GPS-kart - merk urter på stedet (kommer snart)
- Les vitenskapelige publikasjoner relatert til søket ditt
- Søk medisinske urter etter deres effekter
- Organiser dine interesser og hold deg oppdatert med nyheter, kliniske studier og patenter
Skriv inn et symptom eller en sykdom og les om urter som kan hjelpe, skriv en urt og se sykdommer og symptomer den brukes mot.
* All informasjon er basert på publisert vitenskapelig forskning
